Revvity (RVTY) Competitors $91.20 -2.18 (-2.33%) Closing price 10/7/2025 03:59 PM EasternExtended Trading$90.20 -1.00 (-1.10%) As of 10/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RVTY vs. BRKR, TECH, A, DHR, IQV, MTD, TMO, WAT, KEYS, and VLTOShould you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), Waters (WAT), Keysight Technologies (KEYS), and Veralto (VLTO). Revvity vs. Its Competitors Bruker Bio-Techne Agilent Technologies Danaher IQVIA Mettler-Toledo International Thermo Fisher Scientific Waters Keysight Technologies Veralto Bruker (NASDAQ:BRKR) and Revvity (NYSE:RVTY) are related companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings. Which has preferable earnings & valuation, BRKR or RVTY? Revvity has lower revenue, but higher earnings than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$3.37B1.56$113.10M$0.5266.46Revvity$2.76B3.84$270.39M$2.3638.64 Is BRKR or RVTY a better dividend stock? Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.6%. Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Bruker pays out 38.5% of its earnings in the form of a dividend. Revvity pays out 11.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has more volatility and risk, BRKR or RVTY? Bruker has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Revvity has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Do insiders & institutionals believe in BRKR or RVTY? 79.5% of Bruker shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 27.3% of Bruker shares are owned by company insiders. Comparatively, 0.7% of Revvity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to BRKR or RVTY? In the previous week, Bruker had 3 more articles in the media than Revvity. MarketBeat recorded 11 mentions for Bruker and 8 mentions for Revvity. Bruker's average media sentiment score of 0.66 beat Revvity's score of 0.03 indicating that Bruker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 3 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Revvity 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Is BRKR or RVTY more profitable? Revvity has a net margin of 10.19% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 17.89% beat Revvity's return on equity.Company Net Margins Return on Equity Return on Assets Bruker2.31% 17.89% 5.38% Revvity 10.19%7.66%4.73% Do analysts recommend BRKR or RVTY? Bruker presently has a consensus target price of $51.00, indicating a potential upside of 47.57%. Revvity has a consensus target price of $117.93, indicating a potential upside of 29.30%. Given Bruker's higher possible upside, equities research analysts plainly believe Bruker is more favorable than Revvity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 1 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.36Revvity 0 Sell rating(s) 5 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryBruker beats Revvity on 10 of the 18 factors compared between the two stocks. Get Revvity News Delivered to You Automatically Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVTY vs. The Competition Export to ExcelMetricRevvityMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$10.84B$8.18B$6.12B$22.14BDividend Yield0.30%2.81%5.69%3.57%P/E Ratio38.6573.0985.6029.64Price / Sales3.8439.72612.8195.37Price / Cash10.9723.2237.7824.65Price / Book1.456.8913.254.61Net Income$270.39M$247.60M$3.30B$1.01B7 Day Performance-0.61%0.82%3.87%-0.14%1 Month Performance5.68%1.20%8.33%2.28%1 Year Performance-25.26%11.79%88.97%14.59% Revvity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVTYRevvity3.8542 of 5 stars$91.20-2.3%$117.93+29.3%-25.6%$10.84B$2.76B38.6511,000Analyst ForecastBRKRBruker4.9484 of 5 stars$30.88-0.5%$51.30+66.1%-47.6%$4.71B$3.37B59.3911,396TECHBio-Techne4.8331 of 5 stars$52.23+0.7%$70.42+34.8%-19.5%$8.07B$1.22B113.553,100Analyst ForecastAAgilent Technologies3.9089 of 5 stars$123.70+0.3%$140.08+13.2%-3.7%$34.98B$6.51B29.0417,900Analyst ForecastDHRDanaher4.98 of 5 stars$185.87+0.6%$245.91+32.3%-22.4%$132.35B$23.88B39.5563,000Positive NewsAnalyst ForecastIQVIQVIA4.859 of 5 stars$181.00+0.8%$229.64+26.9%-11.0%$30.53B$15.41B26.1988,000Positive NewsMTDMettler-Toledo International3.9684 of 5 stars$1,191.70-1.1%$1,325.56+11.2%-10.9%$24.81B$3.87B30.1817,300Analyst ForecastTMOThermo Fisher Scientific4.889 of 5 stars$461.95-0.5%$588.35+27.4%-9.9%$175.30B$42.88B26.72125,000Positive NewsAnalyst ForecastWATWaters4.6808 of 5 stars$289.19-0.9%$378.73+31.0%-8.9%$17.36B$2.96B26.087,600Trending NewsKEYSKeysight Technologies4.5283 of 5 stars$173.35+0.0%$187.38+8.1%+9.1%$29.79B$4.98B55.2115,500Positive NewsVLTOVeralto3.6038 of 5 stars$105.11+0.5%$114.25+8.7%-5.8%$25.97B$5.19B29.3617,000Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Bruker Alternatives Bio-Techne Alternatives Agilent Technologies Alternatives Danaher Alternatives IQVIA Alternatives Mettler-Toledo International Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Keysight Technologies Alternatives Veralto Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RVTY) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revvity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revvity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
